| 臺大學術典藏 |
2021-03-09T06:46:20Z |
Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study
|
Cheng A.-L.; Su I.-J.; Chen C.-C.; Tien H.-F.; Lay J.-D.; Chen B.-R.; Pu Y.-S.; RUEY-LONG HONG; Shen M.-C.; Wang C.-H.; Chen Y.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:20Z |
Expressions of E-Cadherin and Exon V6-Containing Isoforms of CD44 and their Prognostic Values in Human Transitional Cell Carcinoma
|
Ruey-Long Hong;Pu Y.-S.;Hsieh T.-S.;Chu J.-S.;Lee W.-J.; RUEY-LONG HONG; Pu Y.-S.; Hsieh T.-S.; Chu J.-S.; Lee W.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:19Z |
Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma
|
Ruey-Long Hong;Pu Y.-S.;Chu J.-S.;Lee W.-J.;Chen Y.-C.;Wu C.-W.; RUEY-LONG HONG; Pu Y.-S.; Chu J.-S.; Lee W.-J.; Chen Y.-C.; Wu C.-W. |
| 臺大學術典藏 |
2021-03-04T02:36:03Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Yu-Chieh Tsai;Yu H.-J.;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:02Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.;Hsu C.-H.;Huang C.-Y.;Keng H.-Y.;Yu-Chieh Tsai;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; YU-CHIEH TSAI; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; YU-CHIEH TSAI; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:01Z |
Down regulation of ABCD1 in human renal cell carcinoma
|
Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; Huang C.-Y.; YU-CHIEH TSAI; Wu W.-J.; Huang S.-P.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:36:00Z |
Down-regulation of PKC�a in renal cell carcinoma and its clinicopathological implications.
|
Pu Y.S.; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; Yu H.J.; Lai M.K.; YU-CHIEH TSAI; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
|
Yu-Chieh Tsai;Yeh C.-H.;Tzen K.-Y.;Ho P.-Y.;Tuan T.-F.;Pu Y.-S.;Cheng A.-L.;Cheng J.C.-H.; YU-CHIEH TSAI; Yeh C.-H.; Tzen K.-Y.; Ho P.-Y.; Tuan T.-F.; Pu Y.-S.; Cheng A.-L.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:59Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
Huang K.-H.; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; YU-CHIEH TSAI; Pu Y.-S.; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:58Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; YU-CHIEH TSAI; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; YU-CHIEH TSAI; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma
|
Hsu F.-M.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Tsai C.-L.; YU-CHIEH TSAI; Yu H.-J.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; YU-CHIEH TSAI; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:57Z |
Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells
|
YU-CHIEH TSAI; Ho P.-Y.; Tzen K.-Y.; Tuan T.-F.; Liu W.-L.; Cheng A.-L.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Yu-Chieh Tsai;Lin C.-C.;Hsu C.-H.;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; YU-CHIEH TSAI; Lin C.-C.; Hsu C.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population
|
Lin Y.-C.;Hour T.-C.;Yu-Chieh Tsai;Huang S.-P.;Wu W.-J.;Chen C.-H.;Pu Y.-S.;Chung S.-D.;Huang C.-Y.; Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI; Huang S.-P.; Wu W.-J.; Chen C.-H.; Pu Y.-S.; Chung S.-D.; Huang C.-Y. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma
|
Guo J.-C.;Yu-Chieh Tsai;Pu Y.-S.; Guo J.-C.; YU-CHIEH TSAI; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T08:29:56Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; BOR-RU LIN; Wu M.-S.; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:22:37Z |
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
|
Chen A.-L.; Hsu C.-H.; Lin J.-K.; Hsu M.-M.; Ho Y.-F.; She T.-S.; Ko J.-Y.; Lin J.-T.; Lin B.-R.; MING-SHIANG WU; Yu H.-S.; Jee S.-H.; Chen G.-S.; Chen T.-M.; Chen C.-A.; Lai M.-K.; Pu Y.-S.; Pan M.-H.; Wang Y.-J.; Tsai C.-C.; Hsieh C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:44Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao C.-H.;Liu S.-P.;Pu Y.-S.;Huang C.-Y.;Hong-Jeng Yu;Chen J.; Liao C.-H.; Liu S.-P.; Pu Y.-S.; Huang C.-Y.; HONG-JENG YU; Chen J. |
| 臺大學術典藏 |
2021-02-02T00:43:41Z |
Resistance to paclitaxel is proportional to cellular total antioxidant capacity
|
Ramanathan B.;Jan K.-Y.;Chen C.-H.;Hour T.-C.;Hong-Jeng Yu;Pu Y.-S.; Ramanathan B.; Jan K.-Y.; Chen C.-H.; Hour T.-C.; HONG-JENG YU; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:40Z |
High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan
|
Huang P.-C.;Huang C.-Y.;Huang S.-W.;Lai M.-K.;Hong-Jeng Yu;Chen J.;Pu Y.-S.; Huang P.-C.; Huang C.-Y.; Huang S.-W.; Lai M.-K.; HONG-JENG YU; Chen J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:38Z |
Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: A retrospective study of 1875 cases in Taiwan
|
Chiang I.-N.;Chang S.-J.;Pu Y.-S.;Huang K.-H.;Hong-Jeng Yu;Huang C.-Y.; Chiang I.-N.; Chang S.-J.; Pu Y.-S.; Huang K.-H.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:37Z |
Long-term outcome of hand-assisted laparoscopic radical nephroureterectomy for upper-tract urothelial carcinoma: Comparison with open surgery
|
Chung S.-D.;Chueh S.-C.;Lai M.-K.;Huang C.-Y.;Pu Y.-S.;Hong-Jeng Yu;Huang K.-H.; Chung S.-D.; Chueh S.-C.; Lai M.-K.; Huang C.-Y.; Pu Y.-S.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:37Z |
Intermediate Follow-up of Hand-Assisted Retroperitoneoscopic Nephroureterectomy for Management of Upper Urinary Tract Urothelial Carcinoma: Comparison with Open Nephroureterectomy
|
Chung S.-D.;Huang C.-Y.;Chueh S.-C.;Pu Y.-S.;Lai M.-K.;Hong-Jeng Yu;Huang K.-H.; Chung S.-D.; Huang C.-Y.; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:37Z |
Long-Term Follow-up of Hand-Assisted Laparoscopic Radical Nephrectomy for Organ-Confined Renal Cell Carcinoma
|
Chung S.-D.;Huang K.-H.;Lai M.-K.;Huang C.-Y.;Pu Y.-S.;Hong-Jeng Yu;Chueh S.-C.; Chung S.-D.; Huang K.-H.; Lai M.-K.; Huang C.-Y.; Pu Y.-S.; HONG-JENG YU; Chueh S.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:36Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Tsai Y.-C.;Hong-Jeng Yu;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; Tsai Y.-C.; HONG-JENG YU; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:35Z |
CKD as a Risk Factor for Bladder Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
|
Chung S.-D.;Huang K.-H.;Lai M.-K.;Huang C.-Y.;Chen C.-H.;Pu Y.-S.;Hong-Jeng Yu;Chueh S.-C.; Chung S.-D.; Huang K.-H.; Lai M.-K.; Huang C.-Y.; Chen C.-H.; Pu Y.-S.; HONG-JENG YU; Chueh S.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:34Z |
Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy
|
Huang S.-P.;Huang C.-Y.;Wang J.-S.;Liu C.-C.;Pu Y.-S.;Hong-Jeng Yu;Yu C.-C.;Wu T.T.;Huang C.-H.;Wu W.-J.;Chou Y.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wang J.-S.; Liu C.-C.; Pu Y.-S.; HONG-JENG YU; Yu C.-C.; Wu T.T.; Huang C.-H.; Wu W.-J.; Chou Y.-H.; Wu M.-T. |
| 臺大學術典藏 |
2021-02-02T00:43:33Z |
Comparison between hand-assisted laparoscopic and retroperitoneoscopic nephroureterectomy for the management of upper urinary tract urothelial carcinoma: Analysis of an intermediate follow-up period
|
Chung S.-D.;Chueh S.-C.;Huang C.-Y.;Lai M.-K.;Pu Y.-S.;Hong-Jeng Yu;Huang K.-H.; Chung S.-D.; Chueh S.-C.; Huang C.-Y.; Lai M.-K.; Pu Y.-S.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:33Z |
Primary Mucinous Adenocarcinoma of Renal Pelvis with Carcinoembryonic Antigen Production
|
Ho C.-H.;Lin W.-C.;Pu Y.-S.;Hong-Jeng Yu;Huang C.-Y.; Ho C.-H.; Lin W.-C.; Pu Y.-S.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:32Z |
Characteristics of Female Non-Muscle-Invasive Bladder Cancer in Taiwan: Association with Upper Tract Urothelial Carcinoma and End-Stage Renal Disease
|
Chen C.-H.;Shun C.-T.;Huang K.-H.;Huang C.-Y.;Hong-Jeng Yu;Pu Y.-S.; Chen C.-H.; Shun C.-T.; Huang K.-H.; Huang C.-Y.; HONG-JENG YU; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:29Z |
Long-term outcome of hand-assisted laparoscopic nephroureterectomy for pathologic T3 upper urinary tract urothelial carcinoma
|
Chung S.-D.; Chen S.-C.; Wang S.-M.; Chueh S.-C.; Lai M.-K.; Huang C.-Y.; Pu Y.-S.; Huang K.-H.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:26Z |
Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan
|
Chen C.-H.; Chiou H.-Y.; Hsueh Y.-M.; Chen C.-J.; HONG-JENG YU; Pu Y.-S. |
| 臺大學術典藏 |
2021-02-02T00:43:25Z |
Lymphovascular invasion predicts poor outcome of urothelial carcinoma of renal pelvis after nephroureterectomy
|
Chung S.-D.; Wang S.-M.; Lai M.-K.; Huang C.-Y.; Liao C.-H.; Huang K.-H.; Pu Y.-S.; Chueh S.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:24Z |
Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection
|
Chiang I.-N.;Chang S.-J.;Pu Y.-S.;Huang K.-H.;Hong-Jeng Yu;Huang C.-Y.; Chiang I.-N.; Chang S.-J.; Pu Y.-S.; Huang K.-H.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:23Z |
Diagnostic Value of Finger-guided Prostate Nodule Biopsy Combined With Systemic Random Biopsy
|
Chiang I.-N.; Chang S.-J.; Pu Y.-S.; Huang K.-H.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:23Z |
Choosing the ideal length of a double-pigtail ureteral stent according to body height: Study based on a chinese population
|
Ho C.-H.; Huang K.-H.; Chen S.-C.; Pu Y.-S.; Liu S.-P.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:22Z |
Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma
|
Pu Y.-S.; Huang C.-Y.; Kuo Y.-Z.; Kang W.-Y.; Liu G.-Y.; Huang A.-M.; HONG-JENG YU; Lai M.-K.; Huang S.-P.; Wu W.-J.; Chiou S.-J.; Hour T.-C. |
| 臺大學術典藏 |
2021-02-02T00:43:22Z |
Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors
|
Ho C.-H.; Huang C.-Y.; Lin W.-C.; Chueh S.-C.; Pu Y.-S.; Lai M.-K.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:21Z |
Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups.
|
Huang S.P.;Huang C.Y.;Liu C.C.;Yu C.C.;Pu Y.S.;Chueh S.C.;Hong-Jeng Yu;Wu T.T.;Li C.C.;Huang C.H.;Wu W.J.; Huang S.P.; Huang C.Y.; Liu C.C.; Yu C.C.; Pu Y.S.; Chueh S.C.; HONG-JENG YU; Wu T.T.; Li C.C.; Huang C.H.; Wu W.J. |
| 臺大學術典藏 |
2021-02-02T00:43:21Z |
An audit of nephroureterectomy for upper tract urothelial carcinoma
|
Huang C.-Y.; Chung S.-D.; Wang S.-M.; Liao C.-H.; Lai M.-K.; Huang K.-H.; Pu Y.-S.; Chueh S.-C.; HONG-JENG YU |
| 臺大學術典藏 |
2021-02-02T00:43:21Z |
Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis
|
Lin W.-C.; Chen S.-C.; Hu F.-C.; Chueh S.-C.; Pu Y.-S.; HONG-JENG YU; Huang K.-H. |
| 臺大學術典藏 |
2021-02-02T00:43:16Z |
An Unusual Presentation of Prostate Adenocarcinoma Metastatic to the Oral Cavity
|
Weng W.-C.; Lin W.-C.; Pu Y.-S.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:12Z |
Long-term oncologic outcomes of hand-assisted retroperitoneoscopic radical nephrectomy to treat clinically localized renal cell carcinoma
|
Hung S.-F.; Wang S.-M.; Chung S.-D.; Lai M.-K.; Huang K.-H.; Pu Y.-S.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:12Z |
Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.
|
Pu Y.S.; Huang C.Y.; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; HONG-JENG YU; Lai M.K.; Tsai Y.C.; Wu W.J.; Hour T.C. |
| 臺大學術典藏 |
2021-02-02T00:43:11Z |
Ketoconazole in Taiwanese castration-resistant prostate cancer patients: Evaluation of response rates, durations, and predictors
|
Chiang B.-J.; Pu Y.-S.; HONG-JENG YU; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:43:10Z |
Pneumopelvis, pneumoureter and pneumobladder
|
Weng W.-C.; Pu Y.-S.; HONG-JENG YU; Huang C.-Y. |
